Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine Receptor

Journal of Alzheimer's Disease

Volumn 53, Issue 1, 2016, Pages 337-347

  Hascup, Kevin N ^a   Hascup, Erin R ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha bungarotoxin; Alzheimer's disease; amyloid beta; biosensor; cognition; hippocampus; neurotransmission; nicotinic acetylcholine receptor; presynaptic; tetrodotoxin

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN[1-42]; BUNGAROTOXIN RECEPTOR; GLUTAMIC ACID; ISOFLURANE; TETRODOTOXIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BUNGAROTOXIN; PEPTIDE FRAGMENT; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DENTATE GYRUS; EXTRACELLULAR SPACE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; LIMIT OF DETECTION; MALE; MICROELECTRODE; MICROPIPETTE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CONFORMATION; REPRODUCIBILITY; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; ELECTROSTIMULATION; HIPPOCAMPUS; METABOLISM;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; BUNGAROTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICROELECTRODES; PEPTIDE FRAGMENTS; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN;

EID: 84976430831     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160041     Document Type: Article

References (50)

1. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
2. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112.
3. Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN (2004) The role of beta amyloid in Alzheimer's disease: Still a cause of everything or the only one who got caught? Pharmacol Res 50, 397-409.
4. Jin M, Selkoe DJ (2015) Systematic analysis of timedependent neural effects of soluble amyloid oligomers in culture and in vivo: Prevention by scyllo-inositol. Neurobiol Dis 82, 152-163.
5. Müller-Schiffmann A, Herring A, Abdel-Hafiz L, Chepkova AN, Schäble S, Wedel D, Horn AHC, Sticht H, de Souza Silva MA, Gottmann K, Sergeeva OA, Huston JP, Keyvani K, Korth C (2016) Amyloid-dimers in the absence of plaque pathology impair learning and synaptic plasticity. Brain 139, 509-525.
6. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM,Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
7. Mura E, Lanni C, Preda S, Pistoia F, Sará M, Racchi M, Schettini G, Marchi M, Govoni S (2010) Beta-amyloid: A disease target or a synaptic regulator affecting agerelated neurotransmitter changes? Curr Pharm Des 16, 672-683.
8. Mura E, Zappettini S, Preda S, Biundo F, Lanni C, Grilli M, Cavallero A, Olivero G, Salamone A, Govoni S, Marchi M (2012) Dual effect of beta-amyloid on 7 and 4 2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus. PLoS One 7, e29661.
9. Varga E, Juhász G, Bozsó Z, Penke B, Fülöp L, Szegedi V (2014) Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors. Neural Plast 2014, 584314.
10. Wang HY, Lee DH, Davis CB, Shank RP (2000) Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75, 1155-1161.
11. Konradsson-Geuken A, Gash CR, Alexander K, Pomerleau F, Huettl P, Gerhardt GA, Bruno JP (2009) Second-bysecond analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse 63, 1069-1082.
12. Francis PT (2003) Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18, S15-S21.
13. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545.
14. Zhou Y, Danbolt NC (2013) GABA and glutamate transporters in brain. Front Endocrinol (Lausanne) 4, 165.
15. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65, 1-105.
16. Hascup KN, Hascup ER (2015) Altered neurotransmission prior to cognitive decline in A-PP/PS1 mice, a model of Alzheimer's disease. J Alzheimers Dis 44, 771-776.
17. Hascup ER, af Bjerkén S, Hascup KN, Pomerleau F, Huettl P, Strömberg I, Gerhardt GA (2009) Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex. Brain Res 1291, 12-20.
18. Nicholson C (2001) Diffusion and related transport mechanisms in brain tissue. Reports Prog Phys 64, 815-884.
19. Hascup KN, Rutherford EC, Quintero JE, Day BK, Nickell JR, Pomerleau F, Huettl P, Burmeister JJ, Gerhardt GA (2006) Second-by-second measures of l-glutamate and other neurotransmitters using enzyme-based microelectrode arrays-electrochemical methods for neuroscience-NCBI bookshelf. In Electrochemical Methods for Neuroscience, Borland AC, Michael LM, eds. CRC Press, pp. 407-450.
20. Hascup KN, Hascup ER (2014) Electrochemical techniques for subsecond neurotransmitter detection in live rodents. Comp Med 64, 249-255.
21. Burmeister JJ, Moxon K, Gerhardt GA (2000) Ceramicbased multisite microelectrodes for electrochemical recordings. Anal Chem 72, 187-192.
22. Hinzman JM, Thomas TC, Burmeister JJ, Quintero JE, Huettl P, Pomerleau F, Gerhardt GA, Lifshitz J (2010) Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: An enzyme-based microelectrode array study. J Neurotrauma 27, 889-899.
23. Hascup KN, Hascup ER, Littrell OM, Hinzmann JM, Werner CE, Davis VA, Burmeister JJ, Pomerleau F, Quintero JE, Huettl P, Gerhardt GA (2013) Microelectrode array fabrication and optimization for selective neurochemical detection. In Microelectrode Biosensors, Marinesco S, Dale N, eds. Humana Press, Totowa, NJ, pp. 27-54.
24. Friedemann MN, Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13, 325-332.
25. Paxinos G, Franklin KBJ (2004) The Mouse Brain In Stereotaxic Coordinates, Gulf Professional Publishing.
26. Burmeister JJ, Gerhardt GA (2001) Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem 73, 1037-1042.
27. Hascup ER, Hascup KN, Stephens M, Pomerleau F, Huettl P, Gratton A, Gerhardt GA (2010) Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem 115, 1608-1620.
28. Hascup KN, Hascup ER, Stephens ML, Glaser PEA, Yoshitake T, Mathé AA, Gerhardt GA, Kehr J (2011) Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat:Agenetic rodent model of depression. Neuropsychopharmacology 36, 1769-1777.
29. Burmeister JJ, Pomerleau F, Palmer M, Day BK, Huettl P, Gerhardt GA (2002) Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS. J Neurosci Methods 119, 163-171.
30. Magdesian MH, Nery AA, Martins AHB, Juliano MA, Juliano L, Ulrich H, Ferreira ST (2005) Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta. J Biol Chem 280, 31085-31090.
31. Khan GM, Tong M, Jhun M, Arora K, Nichols RA (2010) beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: Involvement of lipid rafts. Eur J Neurosci 31, 788-796.
32. Mehta TK, Dougherty JJ, Wu J, Choi CH, Khan GM, Nichols RA (2009) Defining pre-synaptic nicotinic receptors regulated by beta amyloid in mouse cortex and hippocampus with receptor null mutants. J Neurochem 109, 1452-1458.
33. Parri HR, Hernandez CM, Dineley KT (2011) Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem Pharmacol 82, 931-942.
34. Waters J (2010) The concentration of soluble extracellular amyloid-protein in acute brain slices from CRND8 mice. PLoS One 5, e15709.
35. Tribollet E, Bertrand D, Marguerat A, RaggenbassM(2004) Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging:Anautoradiographic study in the rat brain. Neuroscience 124, 405-420.
36. Thal DR, Rüb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of A-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59, 733-748.
37. Flood P, Ramirez-Latorre J, Role L (1997) Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 86, 859-865.
38. Gahring LC, Persiyanov K, Dunn D, Weiss R, Meyer EL, Rogers SW (2004) Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J Comp Neurol 468, 334-346.
39. Patti L, Raiteri L, Grilli M, Zappettini S, Bonanno G, Marchi M (2007) Evidence that 7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes. Neurochem Int 51, 1-7.
40. Salamone A, Mura E, Zappettini S, Grilli M, Olivero G, Preda S, Govoni S, Marchi M (2014) Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: The glial contribution. Eur J Pharmacol 723, 314-321.
41. Day BK, Pomerleau F, Burmeister JJ, Huettl P, GerhardtGA (2006) Microelectrode array studies of basal and potassiumevoked release of L-glutamate in the anesthetized rat brain. J Neurochem 96, 1626-1635.
42. Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA (2008) Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 324, 725-731.
43. Francis PT (2003) Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18, S15-S21.
44. Wang J, Dickson DW, Trojanowski JQ, LeeVM(1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol 158, 328-337.
45. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155, 853-862.
46. Robert J, Stukas S, Button E, Cheng WH, Lee M, Fan J, Wilkinson A, Kulic I, Wright SD, Wellington CL (2015) Reconstituted high-density lipoproteins acutely reduce soluble brain A levels in symptomatic APP/PS1 mice. Biochim Biophys Acta 1862, 1027-1036.
47. Boyd-Kimball D, Sultana R, Poon HF, Lynn BC, Casamenti F, Pepeu G, Klein JB, Butterfield DA (2005) Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: Implications for Alzheimer's disease. Neuroscience 132, 313-324.
48. Butterfield DA, Castegna A, Lauderback C, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664.
49. Liu Q, Kawai H, Berg DK (2001) beta-Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 98, 4734-4739.
50. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134.